The Global Economy and the Future of Rights

From Midtown to the Marketplace

When Luigi Mangione pulled the trigger, he didn’t just end a life. He sent ripples through a system. Brian Thompson wasn’t just a CEO—he was the public face of UnitedHealthcare, a corporation woven into the very fabric of American healthcare and global financial markets.

The courtroom ruling that reduced his killing to “just murder” may comfort statute books. But markets are not ruled by statute—they are ruled by sentiment. And sentiment is fragile.

‍

Investor Confidence in a World of Rage

When CEOs become symbols of public anger, the economy trembles. Investors don’t just weigh quarterly earnings; they weigh stability.

• The assassination of a CEO signals systemic vulnerability.

• The failure to call it terrorism signals that the state does not recognize corporate leadership as a national security issue.

• The gap between law and perception becomes a fissure markets cannot price.

The Mangione case matters because it tells investors: the law will not classify corporate violence as systemic terror. Which means risk is borne not by courts but by markets.

‍

Global Implications: America as a Precedent

The United States remains the reference point for global corporate law. When a New York judge rules that the killing of a CEO is not terrorism, it sets an international tone.

• In Europe, where populism rises and farmers blockade roads, corporate leaders may face similar threats.

• In Latin America, where cartels and corporations blur, violence against executives is already a shadow economy.

• In Asia, where conglomerates wield state-level power, leaders may find themselves more exposed than ever.

If America refuses to frame corporate-directed violence as terror, others may follow. The precedent travels faster than the ruling itself.

‍

AI and the Absence of Guide Rails

Layer artificial intelligence on top, and the threat compounds.

• Deepfakes can place CEOs in fabricated scandals.

• Algorithms can amplify calls for violence faster than states can respond.

• AI-generated manifestos can radicalize thousands in hours.

• Machine-driven targeting could identify not just CEOs but their families, their schedules, their vulnerabilities.

Without international legal frameworks, AI becomes the silent accelerant. What Mangione did alone with a handgun could, in the future, be multiplied by machine intelligence into coordinated, simultaneous acts.

Yet courts remain trapped in 20th-century categories. Terrorism requires groups, networks, manifestos. The lone man with AI? Invisible to statute.

‍

The Future of Rights in a Global Economy

The Mangione trial is not only about violence against corporations—it is about the future of rights.

• Speech rights will be tested when AI produces inflammatory content at scale.

• Privacy rights will vanish as corporations surveil to protect themselves.

• Labor rights may shrink as executives retreat behind walls, more accountable to shareholders than to employees.

• Consumer rights could erode as corporations argue that public anger justifies more control, not less.

We may enter a paradoxical era: the more corporations are targeted, the more rights ordinary people lose.

‍

The Law’s Lag, the Market’s Lead

Courts lag. Markets lead. That is the brutal truth.

• Judges dismiss terrorism charges, bound by precedent.

• Markets slash valuations, bound by perception.

• Corporations build higher fortresses, bound by fear.

In the gap between the law’s slow definitions and the market’s instant reactions lies a new instability—one that could rattle not just companies, but nations.

‍

Why These Matter

The Mangione case matters because it is a trial in New York with consequences in Shanghai, Paris, São Paulo, and Lagos. It is not about one man or one CEO. It is about the architecture of rights and risks in a world where corporations are symbols, violence is politicized, and AI accelerates everything.

The global economy is already fragile. Trust is already thin. If law continues to lag, markets will decide. And when markets decide, rights often erode.

Because in the end, the question is not whether Mangione will be convicted. The question is whether our systems—legal, corporate, and global—can survive the next collision of rage, rights, and reality.

‍

Flying Without Aircraft Is Already Here

For most of aviation history, human flight has required an aircraft: a machine large enough to generate lift, carry fuel, accommodate passengers, and surround its occupants with an engineered structure. Emerging personal-flight technologies are beginning to loosen that relationship. Jet suits, powered wings, compact electric vertical-lift systems, autonomous drones, and increasingly sophisticated flight-control technologies suggest that aviation may eventually encompass machines worn, mounted, or summoned rather than conventionally boarded. The viral spectacle is irresistible. A person rises from the ground, accelerates over water, and appears to have acquired a superpower. Yet spectacle obscures the engineering. Human-scale powered flight confronts brutal constraints involving energy density, heat, noise, stability, endurance, payload, weather, redundancy, training, regulation, and the consequences of mechanical failure. A technology can fly successfully and still be unsuitable for mass transportation. That distinction is central to understanding personal aviation. The most plausible near-term applications are unlikely to involve commuters casually flying between homes and offices. Specialist environments — emergency response, defence, offshore infrastructure, inaccessible terrain, inspection, rescue, and certain industrial operations — provide a more credible pathway because the economic value of reaching somewhere quickly can outweigh the technology’s considerable limitations. The deeper development, however, extends beyond jet suits. Aviation is becoming computational. Sensors can stabilise machines faster than human reflexes. Software can continuously adjust thrust. Lightweight materials reduce mass. Autonomous navigation increasingly separates piloting from constant manual control. Electric propulsion enables aircraft configurations that would have been impractical under traditional mechanical architectures. The result is not necessarily the death of the aeroplane. Commercial aircraft remain extraordinarily efficient at moving large numbers of people over long distances. Instead, aviation may be fragmenting into a richer ecosystem: aircraft for distance, drones for autonomous logistics, eVTOL systems for specialised regional movement, and wearable or highly compact systems for particular human-scale missions. The important question is therefore no longer simply, “Can a person fly without an aeroplane?” We already know that certain machines can make that possible. The better question is: when does removing the aircraft make flight more useful?

MAID, longevity and the systems we are designing around the end of human life

Canada’s Medical Assistance in Dying programme has moved an ancient human question into modern medicine: when suffering becomes intolerable, who should have authority over how life ends? In 2024, 16,499 people received MAID—5.1 per cent of deaths in Canada. Yet the headline conceals crucial distinctions: 95.6 per cent were people whose natural deaths were reasonably foreseeable; 4.4 per cent were not. Most recipients had received palliative care, while disability advocates, clinicians, ethicists and policymakers continue to dispute whether safeguards can adequately separate autonomous choice from suffering intensified by inadequate social support. The future makes the question harder. Medicine is simultaneously extending life, managing once-fatal disease, expanding organ transplantation and developing technologies that could prolong healthy longevity. A civilisation capable of keeping people alive for longer must therefore become equally sophisticated about what makes continued life worth living. The central question is larger than MAID: can a society protect the right to choose death without allowing failures of care to narrow the possibility of choosing life?

When Medicine Can Silence A Disease

For four decades, the central challenge of HIV medicine has been control. Antiretroviral therapy can suppress the virus so effectively that people living with HIV can lead long, healthy lives and, when viral load remains undetectable, do not transmit HIV sexually. Yet treatment does not remove the latent viral reservoir embedded within the body, meaning therapy usually must continue. A developing body of HIV research is asking a different question: rather than continually suppressing an active virus, could medicine make its hidden genetic machinery remain silent? A 2025 Science Advances study found that an HIV-derived antisense transcript known as AST could reinforce viral latency in cells from people receiving treatment. Subsequent research confirmed that HIV antisense transcripts occur naturally in people living with the virus. These findings do not constitute an HIV cure. They reveal something potentially more consequential: another biological mechanism that scientists may eventually learn to manipulate. The larger intelligence is about where medicine may be heading—from repeatedly controlling disease towards redesigning the conditions that allow disease to persist.